Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-53759

ABSTRACT: Genomic characterization of ovarian cancer spheroids

OTHER RELATED OMICS DATASETS IN: PRJNA232817

PROVIDER: E-GEOD-53759 | ExpressionAtlas | 2015-07-31

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-GEOD-53759-analysis-methods.tsv	Tabular
	E-GEOD-53759-atlasExperimentSummary.Rdata	Rdata
	E-GEOD-53759-configuration.xml	Xml
	E-GEOD-53759-percentile-ranks.tsv	Tabular
	E-GEOD-53759.condensed-sdrf.tsv	Tabular

Items per page:

1 - 5 of 71

Similar Datasets

Homo sapiens

Project description:Genomic characterization of ovarian cancer spheroids

| PRJNA232817 | ENA

Homo sapiens

Project description:Genomic Characterization of Ovarian Cancer Patient-derived Organoids

| PRJNA810525 | ENA

Comparative genomic hybridization of cell lines from 9 different cancer tissue of origin types (Breast, Central Nervous System, Colon, Leukemia, Melanoma, Non-Small Cell Lung, Ovarian, Prostate, Renal) from NCI-60 panel

Project description:Array comparative genomic hybridization characterization and comparison of cell lines from 9 different cancer tissue of origin types (Breast, Central Nervous System, Colon, Leukemia, Melanoma, Non-Small Cell Lung, Ovarian, Prostate, Renal) from NCI-60 panel.

2005-11-23 | E-TABM-65 | biostudies-arrayexpress

Proteomic characterization of epithelial ovarian cancer

Project description:Integrative proteomic characterization of epithelial ovarian cancer.

2024-05-23 | PXD053625 |

Genomic characterization of cisplatin response uncovers priming of cispla-tin-induced genes in a resistant cell line

Project description:We conducted a comprehensive genomic characterization of the cisplatin sensitive A2780 ovarian cancer cell line compared to A2780cis, its resistant derivative. The data includes eXcision Repair-sequencing (XR-seq) to map cisplatin repair,RNA-Seq to characterize gene expression and ATAC-Seq to detect changes in chromatin accessibility.

2021-06-07 | GSE173201 | GEO

Genetically defined syngeneic mouse models of ovarian cancer as tools for the discovery of combination immunotherapy (Exome)

Project description:Purpose: There are three goals of this study: 1. To compare the genomic, exome and chromatin accessiblity profiles of the specific engineered fallopian tube cells of high-grade serous tubo-ovarian cancer (HGSC) models (this study) using whole-exome, whole-genome and ATAC-seq sequencing. Methods: For whole-exome analysis, genomic DNA was extracted from the cell lines mentioned below. Conclusions: We conclude that whole-exome, whole-genome and ATAC-seq characterization would expedite genetic network analyses and permit the dissection of complex biological functions.

2020-11-17 | GSE159253 | GEO

Beyond HRD status: Comprehensive Molecular Characterization of Advanced Epithelial Ovarian Cancer

Project description:Molecular characterization of patients enrolled in a clinical phase II study in relapsed ovarian cancer

2024-11-11 | PRJEB82346 | EVA

Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions [H3K4me3]

Project description:In the current study we performed characterization of 18 different in vitro models of high-grade serous (HGSOC), low-grade serous (LGSOC), mucinous (MOC), endometrioid (ENOC) and clear cell (CCOC) carcinoma. This study seeks to fill in this gap by generating an integrative Ovarian Cancer Regulatory Atlas (OCRA) of 18 ovarian normal and cancer cells profiled for epigenomic, transcriptomic, chromatin state and chromatin looping signatures.

2024-03-18 | GSE261637 | GEO

Identify the cancer stem cells expression characteristics in ovarian and breast cancer

Project description:The identification and characterization of subpopulations of cancer stem cells (CSCs) provide new understandings and possible therapeutic implications in cancer biology. We found the ovarian cancer sphere cells possessed CSCs properties maintained self renewal, drug resistance, and tumorigenesis. Using high-throughput microarray system, we identified common GO terms and pathway signatures significantly enriched in ovarian and breast cancer stem cells. Ovarian and breast cancer cells were cultured in sphere formation conditions, and total RNA from those spheres and conresponding adhered cell was hybridized on Affymetrix microarrays.

2013-11-25 | E-GEOD-43657 | biostudies-arrayexpress

Genetic changes in high-grades serous ovarian cancer

Project description:Comparative genomic hybridization analysis on advanced stage high-grade serous ovarian cancer.

2009-10-02 | GSE18154 | GEO